跳至主要内容
临床试验/NCT03716193
NCT03716193招募中不适用

Measurement of the Partial Pressure of Oxygen in Cutaneous Tumors Using Electron Paramagnetic Resonance (EPR) Oximetry

West Virginia University2 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2019年10月17日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
40
试验地点
2
主要终点
Assess the change in oxygenation of cutaneous tumors from hyperoxygenation therapy during the standard therapy for the disease

研究概览

简要总结

This protocol will take measurements of a variety of tumors involving the skin in order to assess changes in tumor oxygen from hyperoxygenation therapy and standard cancer-directed treatments, to demonstrate the clinical feasibility of using in vivo Electron Paramagnetic Resonance (EPR) Oximetry to obtain clinically useful measurements of tumor oxygen levels from cancer patients.

详细描述

All patients in this study will receive standard of care therapy for their cancer at the discretion of their treating physician(s). All subjects will be assigned to one of the four cohorts for which they qualify; there is no randomization and no stratification within the cohorts.

Cohort 1 - Patients who will receive definitive surgery for a primary malignancy of the skin

Cohort 2 - Patients who will receive definitive radiation (+/- concurrent systemic therapy) for a primary malignancy of the skin

Cohort 3 - Patients who will receive palliative radiation (+/- concurrent systemic therapy) for any tumor involving the skin

Cohort 4 - Patients who will receive systemic therapy alone (without radiation) for any tumor involving the skin

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Other
盲法
None

入排标准

年龄范围
18 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Pathology-proven (histology or cytology) malignancy of any histology and site of origin
  • Visible tumor (primary or metastasis) involving the skin of at least 6 mm in diameter
  • Negative serum or urine pregnancy test within 72 hours prior to registration for women of childbearing potential

排除标准

  • Implanted electric, magnetic or mechanically activated devices like a pacemaker, defibrillator, nerve stimulator, cochlear implant or portable infusion pump. Also individuals who have any non-MRI compatible implants
  • Individuals who have a ferromagnetic foreign body located in their body
  • Prior adverse reaction to a charcoal product (e.g., a local hypersensitive response from a black tattoo or from ingestion of activated charcoal)
  • Prior adverse reaction to gum Arabic, which is an ingredient in the India ink
  • Prior allergic reaction to medical adhesives
  • Psychiatric illness/social situations that would limit compliance with study requirements
  • Pregnant or lactating women. There is no known harm to the woman or her fetus from participating; this is precautionary only

结局指标

主要结局

Assess the change in oxygenation of cutaneous tumors from hyperoxygenation therapy during the standard therapy for the disease

时间窗: From the first oxygen measurement to one month after the completing standard therapy

Tumor oxygen kinetics will be measured by EPR oximetry under ambient conditions, during hyperoxygenation therapy (100% O2 administered via a non-rebreather face mask), and immediately after hyperoxygenation therapy.

次要结局

  • To characterize temporal variations in oxygenation of cutaneous tumors over a course of local radiation therapy and/or systemic chemotherapy or immunotherapy(From the first oxygen measurement to one month after the completing standard therapy)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Todd Tenenholz

Radiation Oncologist, Assistant Professor

West Virginia University

研究点 (2)

Loading locations...

相似试验

Measurement of the Partial Pressure of Oxygen in... | 临床试验